COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.
The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]
COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]
Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]
Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.
Honda Accord |
|
| 2.0 RS e:HEV | IDR 970.900.000 |
Honda BR-V |
|
| S MT | IDR 297.300.000 |
| E MT | IDR 312.800.000 |
| E CVT | IDR 325.500.000 |
| PRES CVT | IDR 350.400.000 |
| PRES with Honda Sensing CVT | IDR 370.400.000 |
Honda Brio |
|
| S MT | IDR 170.400.000 |
| E MT | IDR 185.500.000 |
| E CVT | IDR 202.500.000 |
| RS MT | IDR 248.200.000 |
| RS CVT | IDR 258.200.000 |
| RS MT TWO TONE | IDR 250.700.000 |
| RS CVT TWO TONE | IDR 260.700.000 |
Honda City Hatchback |
|
| RS HS CVT | IDR 384.500.000 |
| RS HS CVT TWO TONE | IDR 387.000.000 |
Honda Civic RS |
|
| RS CVT | IDR 626.300.000 |
Honda Civic Type R |
|
| 2.0 MT | IDR 1.445.500.000 |
Honda CR-V |
|
| 1.5 TURBO CVT | IDR 759.000.000 |
| 2.0 RS e:HEV | IDR 825.800.000 |
Honda HR-V |
|
| 1.5 L S CVT | IDR 392.100.000 |
| 1.5 L E CVT | IDR 412.900.000 |
| 1.5 L SE CVT | IDR 433.500.000 |
| 1.5T RS CVT | IDR 551.400.000 |
| 1.5 L E CVT TWO TONE | IDR 415.400.000 |
| 1.5L SE CVT TWO TONE | IDR 436.000.000 |
| 1.5 T RS TWO TONE | IDR 553.900.000 |
Honda WR-V |
|
| 1.5 E MT | IDR 280.700.000 |
| 1.5 E CVT | IDR 290.700.000 |
| 1.5 RS CVT | IDR 310.700.000 |
| 1.5 RS CVT HS | IDR 330.700.000 |
| 1.5 RS CVT Two Tone | IDR 313.200.000 |
| 1.5 RS CVT HS Two Tone | IDR 333.200.000 |
New Honda City |
|
| 1.5 E CVT | IDR 420.700.000 |